TI
CLLS

tru Independence’s Cellectis CLLS Stock Holding History

tru Independence’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-450
Closed -$8 – 416
2020
Q2 		$8 Buy
450
+146
+48% +$2.22K ﹤0.01% 626
2020
Q1 		$3 Hold
304
– – ﹤0.01% 582
2019
Q4 		$3K Buy
+304
New +$4.06K ﹤0.01% 745

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

tru Independence's CLLS Position: Q3 2020 in Review

tru Independence sold out of Cellectis (CLLS) in Q3 2020, closing a stake of 450 shares — an estimated $8 sold.

tru Independence first reported a position in CLLS in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q4 2019. 74 funds tracked by Wall St. Rank hold CLLS as of Q3 2020.

  • tru Independence reported no remaining Cellectis position as of Q3 2020 after selling out during the quarter.
  • tru Independence sold 450 Cellectis shares in Q3 2020, an estimated $8.
  • tru Independence first reported a position in Cellectis in Q4 2019 and held it in 3 quarters.
  • tru Independence's Cellectis position peaked at $3K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Cellectis as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.